Home / Stocks / Vineet Laboratories Ltd
VINEETLAB

Vineet Laboratories Ltd Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹38.55

Change

+0.16 (0.42%)

Open

₹38.82

Prev. Close

₹38.39

Day High

₹39.2

Day Low

₹36.42

Volume Analysis

Traded

175,355

Delivered

124,690

Delivery %

71.11%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (2)

  • •Promoter holding is falling
  • •Below-average fundamentals quality score (35/100)

Opportunities (0)

No signal for this stock

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹42.48 ₹40.84 ₹39.7 ₹38.06 ₹36.92 ₹35.28 ₹34.14
Fibonacci ₹40.84 ₹39.78 ₹39.12 ₹38.06 ₹37.0 ₹36.34 ₹35.28
Camarilla ₹39.31 ₹39.06 ₹38.8 ₹38.06 ₹38.3 ₹38.04 ₹37.79

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

+7.47%

1 Week

+1.8%

1 Month

+1.39%

3 Months

+1.96%

6 Months

+8.29%

1 Year

-8.48%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Company Overview

Sector

Healthcare

Source: Screener.in (Consolidated figures) — data as of 15 Nov 2026. Not investment advice.

TopFund Analysis

Vineet Laboratories Ltd scores weakly on TopFund's composite fundamentals check within the Healthcare sector, at 35/100. The strongest factor is Risk & Volatility (52/100), while Corporate Governance (15/100) is the weakest area to weigh before deciding. Notably: Promoter holding is falling; below-average fundamentals quality score (35/100).

TopFund Score — Fundamentals Quality

35/100 — Weak

Data confidence: 59/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Corporate Governance

15

Institutional Ownership

30

Risk & Volatility

52

Liquidity

52

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

No deviation in rights issue fund utilization for quarter ended September 30, 2026; funds raised were Rs 2,996.81 lakh.

Book closure from 24–30 Nov 2026 for the 10th AGM on 30 Nov 2026 via VC/OAVM.

Source: BSE regulatory filings, via Screener.in.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 37.55% → 5.98%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 62.2% 62.5% 62.49% 63.93% 64.15% 64.15% 70.74% 84.11% 87.54% 93.67% 93.52% 93.78%
Promoters 37.55% 37.5% 37.5% 36.07% 35.85% 35.85% 29.26% 15.89% 12.46% 5.98% 5.98% 5.98%
FII 0.24% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.36% 0.5% 0.24%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Vineet Laboratories Ltd (this stock) — — — —
Sun Pharmaceutical Ind L 451,075 36.7 5.05 16.0%
Divi S Laboratories Ltd 294,139 86.1 16.34 16.5%
Torrent Pharmaceuticals L 177,632 81.8 9.67 27.4%
Apollo Hospitals Enter. L 125,893 55.6 11.86 21.5%
Laurus Labs Limited 125,380 93.6 20.73 18.3%
Zydus Lifesciences Ltd 118,693 26.2 4.27 21.2%

Which Mutual Funds Hold Vineet Laboratories Ltd?

Frequently Asked Questions about Vineet Laboratories Ltd

Community Sentiment

What are other investors saying about Vineet Laboratories Ltd?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.